Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Indian Clinical Research Sector: Hope And Despair Amid Shutdowns

Executive Summary

India's clinical research segment has had a rough time of late. Uncertainties, evolving regulations and compliance deviations have hurt the sector that is now scarred with firms downing the shutter, mistrust and constant speculation. Scrip spoke to a number of CROs who appear to have weathered the storm, but it seems the industry may not be out of the woods just yet.


Related Content

India New Trial Rules - Sponsors Interested But 'FAQ' Could Help
India’s Expanded Trial Waiver Proposal Sets R&D Site Inspection Clause
India Global Trial Hub Dreams Still Distant As Concerns Linger
India Tweaks More Trial Rules But Can It Change The Narrative?
Semler Dirty Data: EMA Suspends Over 200 Products; Stings Indian CROs
US NIH Resumes Indian Trials, Will Others Follow?
India Tweaks Audio-Visual Norms For Trials
Indian CRO segment in the throes of a shakeout?
Indian court sets 3-parameter format for trial applicants


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts